Initial assessment included history and physical examination, full blood count, routine biochemistry, hormone receptor status, chest X-ray, electrocardiogram and MUGA scan.
On day 1 of each cycle, patient evaluation also included liver and renal functions, performance status, chest X-ray, and toxicity scoring according to CTC.
Pretreatment evaluation included the patient's history, physical examination, performance status, chest X-ray, complete blood count, blood chemistry, and computed tomography (CT) scan or magnetic resonance imaging (MRI) of the head and neck.
This was a history and management case and the management response of the candidates depended heavily on the SP's history and his facial expressions showing concern for his current health status (chest pain).
Multivariate models using gender, age, ethnic origin, residence, site of infection, status (new or relapse), drug resistance, BCG status, chest x-ray and cavity were analyzed and potential interactions were assessed for significance.
Each patient in a genetic cluster was examined to determine the following: 1) the period of infectivity (by reviewing date of diagnosis, disease type, smear status, chest radiology results, and date treatment started), 2) name of contacts identified, and 3) how and where the patient spent his or her time during the period of infectivity.
In the remaining 10 patients, HRCT was not indicated as clinical status, PFT, chest x-ray and (except for one asymptomatic patient) VE/VCO2 were normal, and hence the probability of PVOD is considered very low.
A pretreatment evaluation included complete medical history, physical examination, evaluation of performance status, urinalysis, chest radiograph, and diagnostic studies assessment such as CT scan.
Independent predictors of survival in CALGB study were performance status, age, chest pain, weight loss, leukocyte count, and haemoglobin level, whereas they were histology, performance status, gender, and leukocyte count in the EORTC study.
We suggest that high-risk patients are those with a thin body status, thin chest wall, atrophic neck and thoracic muscles, a history of chronic respiratory diseases and heavy long-time smokers.
Contraindications to rib surgery for microtia reconstruction include high-risk surgical status and chest-wall deformities [1 2].
